Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
Go back to Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation| (NASDAQ: TVGN) | Delayed: 4.41 -0.37 (7.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.78 | 52 Week High | $ | |||
| Open | $4.76 | 52 Week Low | $ | |||
| Day High | $4.78 | P/E | N/A | |||
| Day Low | $4.01 | EPS | $ | |||
| Volume | 19,863 | |||||
| (NASDAQ: TVGNW) | Delayed: 0.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.05 | 52 Week High | $ | |||
| Open | $0.05 | 52 Week Low | $ | |||
| Day High | $0.05 | P/E | N/A | |||
| Day Low | $0.05 | EPS | $ | |||
| Volume | 447,975 | |||||
